Clinical Evidence on GLP-1, Dual, and Triple Agonists in Adolescents The clinical evidence surrounding GLP-1RAs and their dual and triple agonist counterparts has grown significantly in recent years
But that connection is indirect, untested in patch form, and nowhere close to replicating what prescription GLP-1 receptor agonists like semaglutide or tirzepatide do
Their use in therapeutic settings is entirely off-label, and they must be compounded by an accredited pharmacy under a physician's prescription
Compounded formulations may not have the same stability-enhancing excipients that brand-name products contain, making them potentially more sensitive to temperature fluctuations
Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE
PubMed laboratory research record [PMID: 21827492] PubMed record related to this compound for laboratory literature review